Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00135356

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

HIV-Associated Lipodystrophy Syndrome Clinical Trial

Official title:
A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing a Reyataz-Based Substitution Approach in the Management of Lipodystrophy Syndrome. Research Into Atazanavir in Lipodystrophy (The REAL Study)

Clinical Trial Summary

The purpose of this clinical research study is to learn if human immunodeficiency virus (HIV)-infected subjects with abdominal fat accumulation on their highly active antiretroviral treatment (HAART) regimen have better changes in fat distribution after switching to atazanavir-ritonavir than those remaining on their current protease inhibitor boosted HAART regimen.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00135356
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Completed
Phase Phase 4
Start date July 2005
Completion date June 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT04340388 - Contribution of Dolutegravir to Obesity and Cardiovascular Disease Phase 4
Completed NCT00069004 - A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth N/A
Terminated NCT00122668 - Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients Phase 4
Completed NCT01848340 - An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects Phase 1
Not yet recruiting NCT00662181 - Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone N/A
Completed NCT00130286 - Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance Phase 1/Phase 2
Active, not recruiting NCT00135460 - Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients Phase 4
Active, not recruiting NCT00122226 - MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase 4
Completed NCT00646984 - Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy Phase 4
Completed NCT00192660 - HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) Phase 4
Terminated NCT00148850 - Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients Phase 3
Completed NCT00383734 - Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE Phase 3
Completed NCT01359917 - Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome N/A